User:Mr. Ibrahem/Tasimelteon

Tasimelteon, sold under the brand name Hetlioz among others, is a medication used to treat non-24-hour sleep–wake disorder. It is taken by mouth, an hour before bedtime. Benefits may take months to occur.

Common side effects include headache, sleepiness, nausea, and dizziness. Safety in pregnancy is unclear. It works by activating the melatonin receptor.

Tasimelteon was approved for medical use in the United States in 2014 and Europe in 2015. In the United States it costs about 23,000 USD per month as of 2021. Despite being approved in Europe and available in Germany it is not sold in the United Kingdom as of 2021.